Targovax AS (Oncos)

APIM Therapeutics AS

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses to treat patients with advanced solid tumours and multiple cancers.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Oncorus

This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Asgard Therapeutics

The company develops gene therapies that reprogramme cancer cells into immune cells for patients with various types of tumours.

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.

Onxeo S.A. (TopoTarget A/S)

This clinical-stage biotechnology company develops oncology drugs targeting tumour DNA damage response for patients with rare cancers and unmet medical needs.